Previous Close | 1.5100 |
Open | 1.5200 |
Bid | 1.3100 x 3100 |
Ask | 0.0000 x 1800 |
Day's Range | 1.4700 - 1.5800 |
52 Week Range | 1.4700 - 4.2500 |
Volume | |
Avg. Volume | 1,135,598 |
Market Cap | 271.206M |
Beta (5Y Monthly) | 1.11 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.2700 |
Earnings Date | Nov 01, 2023 - Nov 06, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 5.75 |
CONCORD, Calif., September 12, 2023--Cerus Corporation (Nasdaq: CERS) announced today that Kevin Green, Cerus’ chief financial officer, is scheduled to participate at the 2023 Cantor Global Healthcare Conference on Tuesday, September 26, at 10:30 a.m. EST.
Cerus (CERS) delivered earnings and revenue surprises of -40% and 4.77%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
CONCORD, Calif., August 02, 2023--Cerus Corporation (Nasdaq: CERS) today announced financial results for the second quarter ended June 30, 2023.